Not provided
Not provided
Not provided
Not provided
Not provided
In adequate enrollment
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Vitamin D status has been negatively associated with the presence of type II DM and glycemic control. However, a cause-effect relationship between vitamin D deficiency and glycemic control has not been established. The investigators plan to conduct a double blind, randomized, placebo controlled trial on the effect of vitamin D supplementation on glycemic control in Type II DM.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| vitamin D3 2000 IU | Experimental |
| |
| vitamin D3 5000 IU | Experimental |
| |
| Placebo | Placebo Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| vitamin D3 2000 IU | Drug | vitamin D3 2000 IU orally, daily for 6 months |
|
| Measure | Description | Time Frame |
|---|---|---|
| Area under the curve of HA1C. | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Area under the curve for BP | 6 months | |
| area under the curve of weight | 6 months | |
| area under the curve for 25 OH vitamin D level |
Not provided
Inclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Muhammad M Hammami, MD, PhD | King Faisal Specialist Hospital & Research Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| King Faisal Specialist Hospital & Research Center | Riyadh | 11211 | Saudi Arabia |
Not provided
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D014808 | Vitamin D Deficiency |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D002762 | Cholecalciferol |
| ID | Term |
|---|---|
| D002782 | Cholestenes |
| D002776 | Cholestanes |
| D013256 | Steroids |
| D000072473 | Fused-Ring Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| vitamin D3 5000 IU | Drug | vitamin D3 5000 IU orally, daily for 6 months |
|
|
| Placebo | Drug | placebo orally, daily for six months |
|
| 6 months |
| area under the curve of fasting blood glucose | 6 months |
| area under the curve of 2 hour post breakfast glucose | 6 months |
| fasting insulin to glucose ratio | 6 months |
| incidence of hypercalcemia | 6 months |
| incidence of hypercalciuria | 6 months |
| D001361 | Avitaminosis |
| D003677 | Deficiency Diseases |
| D044342 | Malnutrition |
| D009748 | Nutrition Disorders |
| D011083 |
| Polycyclic Compounds |
| D013261 | Sterols |
| D014807 | Vitamin D |
| D012632 | Secosteroids |
| D008563 | Membrane Lipids |
| D008055 | Lipids |